<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>personalized medicine autism &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/personalized-medicine-autism/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 13 Dec 2025 15:30:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>personalized medicine autism &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Targeting Endocannabinoidome-Gut-Brain Axis for Autism Therapy</title>
		<link>https://bioengineer.org/targeting-endocannabinoidome-gut-brain-axis-for-autism-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 15:29:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ASD therapeutic targets]]></category>
		<category><![CDATA[Autism Therapy]]></category>
		<category><![CDATA[Endocannabinoid System]]></category>
		<category><![CDATA[endocannabinoidome-gut-brain axis]]></category>
		<category><![CDATA[gut microbiome-brain interaction]]></category>
		<category><![CDATA[Gut-brain axis]]></category>
		<category><![CDATA[Microbiome]]></category>
		<category><![CDATA[personalized medicine]]></category>
		<category><![CDATA[personalized medicine autism]]></category>
		<guid isPermaLink="false">https://bioengineer.org/targeting-endocannabinoidome-gut-brain-axis-for-autism-therapy/</guid>

					<description><![CDATA[A groundbreaking study has emerged that delves into the intricate relationship between the endocannabinoid system, the gut microbiome, and the brain, presenting intriguing avenues for therapeutic breakthroughs in autism spectrum disorder (ASD). Researchers, led by Campanale, Siniscalco, and Di Marzo, have proposed a novel conceptual framework—the endocannabinoidome-gut microbiome-brain axis—that could revolutionize the way we understand [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">307351</post-id>	</item>
	</channel>
</rss>
